The Oncology Institute Inc. (TOI)
NASDAQ · Healthcare
The Oncology Institute Inc. Income Statement 2020–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | 502.7M | 393.4M | 324.2M | 252.5M | 203.0M | 187.5M |
| Gross Profit | — | — | — | — | — | — |
| Profitability | ||||||
| Operating Income | -36.1M | -60.1M | -77.0M | -82.0M | -45.9M | -8.2M |
| EBITDA | -29.1M | -53.8M | -71.1M | -77.5M | -42.5M | -5.0M |
| Net Income | -60.6M | -64.7M | -83.1M | 152,000 | -10.9M | -14.3M |
| Per Share Data | ||||||
| EPS (diluted) | $-0.54 | $-0.71 | $-0.92 | $-0.21 | $-0.16 | $-0.24 |
| Shares Outstanding (dil.) | 92M | 75M | 74M | 81M | 66M | 59M |
The Oncology Institute Inc. Income Statement — FAQ
The Oncology Institute Inc. (TOI) income statement over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TOI's income statement history?
The chart and table above show The Oncology Institute Inc.'s income statement by year and by quarter, including the growth rate.